Todos os estudos
RecrutamentoFASE2INTERVENCIONISTA

Treatment of Ectopic Calcification in Fahr's Disease or Syndrome

This research is investigating a condition called Fahr's disease or syndrome, where calcium deposits build up in certain parts of the brain. This can lead to various symptoms like memory problems, movement difficulties, and mood changes, usually starting in adulthood. Currently, there isn't a specific treatment to stop the disease from getting worse. However, there's a small hint that a type of drug used for bones, called alendronate (a bisphosphonate), might help. This new study aims to properly test if these bisphosphonate drugs can make a real difference for people with Fahr's disease, or if they have no effect compared to a dummy treatment (placebo).

Em resumo

Status
Recrutamento
Fase
FASE2
Patrocinador
UMC Utrecht
Meta de inscrição
98
Iniciar
03 Apr 2023
Conclusão estimada
01 Dez 2027

Sobre o que é este estudo?

Imagine tiny specks of calcium building up in a very important part of your brain called the basal ganglia. This is what happens in a condition called Fahr's disease or syndrome. When doctors don't know why it's happening, they usually call it Fahr's disease. If they find another reason for the calcium build-up, they might call it Fahr's syndrome instead. These calcium deposits can affect how the brain works, leading to a variety of symptoms like problems with memory, thinking, movement, speech, or even mood changes. These symptoms usually appear when a person is between 30 and 50 years old and can slowly get worse over time, making everyday tasks more difficult and affecting their quality of life.

At the moment, there aren't any treatments that can stop Fahr's disease from progressing or reverse its effects. However, doctors have noticed in a few patients that a medicine usually used for bones, called alendronate, seemed to help. This medicine belongs to a group of drugs called bisphosphonates. This new study is being done to see if this type of medicine can actually be an effective treatment for a wider group of people with Fahr's disease or syndrome.

The main goal of this study is to properly test if bisphosphonates can improve the symptoms and quality of life for people with Fahr's disease. Participants will either receive the active drug (etidronate, another bisphosphonate) or a dummy treatment (placebo). By comparing the two groups, researchers hope to understand if bisphosphonates can play a role in managing this condition and potentially offer a new treatment option in the future.

Pontos principais

  • The study is for Fahr's disease or syndrome.
  • It's testing a drug called Etidronate against a placebo.
  • Symptoms of Fahr's can include memory, movement, and mood changes.
  • Currently, there are no specific treatments for Fahr's disease.
  • The study aims to see if bisphosphonate drugs can help manage the condition.

Quem pode ser elegível?

This study is looking for adults aged 18 or older.

To be considered for the study, you must have a formal diagnosis of Fahr's disease or syndrome. This diagnosis is usually made based on the symptoms you experience and a special head scan (CT scan) that clearly shows calcium build-ups in both sides of a specific part of your brain called the basal ganglia. The amount of calcium seen on the scan must be higher than what would be expected for your age to help confirm it's Fahr's disease, not just age-related changes.

Additionally, having a family history of Fahr's disease (meaning close relatives have it) or having certain genetic changes linked to the condition can also support the diagnosis and your eligibility for this study.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. Você tem 18 anos ou mais?
  2. Have you been diagnosed with Fahr's disease or syndrome?
  3. Do you have calcium build-ups in specific parts of your brain visible on a CT scan?
  4. Are these calcium levels higher than what's expected for your age?
  5. Do you have a family history of Fahr's disease or known genetic changes linked to it (this helps, but might not be required)?
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

The information provided does not detail the specifics of what taking part will involve, such as the number of visits, specific assessments, or the total duration of the study. However, it mentions that participants will either receive the study drug (Etidronate) or a placebo (a dummy treatment). This usually means you would be taking medication regularly according to the study's instructions. There would likely be regular appointments to monitor your health, how you are responding to the treatment, and to check for any side effects. You would also have check-ups to assess your symptoms and overall well-being. Detailed information about what you would need to do will be provided if you are considered for the study.

Riscos e benefícios potenciais

Participating in a clinical trial may offer potential benefits, such as receiving a new investigational treatment that might improve your condition, or contributing to medical knowledge that could help others in the future. However, there are also potential risks. The study treatment (Etidronate) may have side effects, which would be explained to you. There's also a chance you could receive a placebo, meaning you wouldn't get the active drug. You have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Localizações (2)

  • Centro Médico Universitário de Utrecht
    Código postal verificado
    Utrecht, Países Baixos· Recrutamento
  • University College London Hospital
    Código postal verificado
    Londres, Reino Unido· Ainda não recrutando

Perguntas frequentes

What is Fahr's disease?

It's a condition where calcium deposits build up in parts of the brain, which can lead to various symptoms like memory or movement problems.

Why are you studying this particular drug?

Early observations suggest that medicines like Etidronate, used for bone conditions, might help with Fahr's disease, and we want to test this properly.

Will I definitely get the active drug?

No, participants will either receive the study drug (Etidronate) or a placebo (a dummy treatment), chosen randomly, so we can compare their effects.

Quem está financiando esta pesquisa?

The information provided does not specify the funding source for this trial.

Onde este estudo está ocorrendo?

The provided summary doesn't state the specific locations where this trial is being conducted.

Como saber mais

Huiberdina L Koek, MD PhD

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Interessado em participar?

Registre seu interesse

Compartilhe seus detalhes e a equipe de pesquisa para "Treatment of Ectopic Calcification in Fahr's Disease or Synd…" entrará em contato com você se você for elegível. Sempre fale com seu médico antes de concordar em participar.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.